Ceftriaxone (Rocephin) for Gonorrhea: Dosage and Expected Symptom Relief
Recommended Regimen (CDC 2021+)
- Uncomplicated urogenital/rectal/pharyngeal gonorrhea: Ceftriaxone 500 mg IM single dose (for persons <150 kg; 1 g if ≥150 kg).
- Note: The older 125 mg dose is no longer recommended due to rising antimicrobial resistance.
- If chlamydia co-infection not excluded, add doxycycline 100 mg PO BID × 7 days.
Symptom Resolution Timeline
- Urethral discharge/dysuria: typically improve within 24–72 hours.
- Rectal/pharyngeal symptoms: similar timeline.
- Persistent symptoms >7 days → re-evaluate for resistance, reinfection, or alternative diagnosis.
Follow-Up
- Test-of-cure (NAAT) at 7–14 days if treated with non-recommended regimen, pregnant, or pharyngeal infection.
- Re-screen at 3 months (high reinfection rate).
- Partner notification and treatment essential.
Always verify current local guidelines as resistance patterns and recommendations evolve.
Gonorrhea - Related Articles
- Gonorrhea Transmission: Primary Routes and Skin Contact Risk
- Gonorrhea and Syphilis Co-infection: Risks, Symptoms, and Importance of Testing
- White Bumps on Mons Pubis: Differential Diagnosis and When to See a Doctor
- Pyrogenic Reaction After IV Therapy: Causes, Symptoms & Management
- Gonorrhea Testing After Miscarriage: Is It Routine?
- Leukocoria: Understanding the 'White Pupil' - Causes & What to Do
- Marijuana Use During Gonorrhea Treatment: Interactions and Advice
